Item 5.08 Shareholder Director Nominations.
To the extent applicable, the information in Item 8.01 of this Current Report on
Form 8-K is incorporated by reference into this Item 5.08.
Item 8.01 Other Events.
On September 29, 2022, the Board of Directors of Nuo Therapeutics, Inc. (the
"Company") determined that the Company's 2022 Annual Meeting of Stockholders
(the "Annual Meeting") will be held at the Company's principal executive office
at 8285 El Rio, Suite 190, Houston, Texas on December 2, 2022, or as otherwise
set forth in the Company's notice and proxy statement for the Annual Meeting to
be filed no less than 40 days prior to the Annual Meeting. Stockholders of
record of the Company's common stock as of the close of business on September
30, 2022 will be entitled to notice of, and to vote at, the Annual Meeting.
Stockholders of the Company who wish to have a proposal, including nominations
of persons for election to the Board of Directors, considered for inclusion in
the Company's proxy materials for the Annual Meeting must ensure that such
proposal is received by, on or before the close of business on October 10, 2022,
which date the Company has determined to be a reasonable time before it expects
to begin to print and send its proxy materials, and which complies with the
requirements of the Amended and Restated By-Laws of the Company as adopted May
5, 2016 (the "By-Laws"). To be eligible for inclusion in the proxy materials for
the Annual Meeting, any such proposal must also meet the requirements set forth
in the rules and regulations of the Securities and Exchange Commission and in
the By-Laws. Proposals and notices must be in writing and received by the
Company's Secretary, David Jorden, addressed to: Nuo Therapeutics, Inc. Board of
Directors, Attn: Secretary, 8285 El Rio, Suite 190, Houston, Texas 77054.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
NUO THERAPEUTICS, INC. 
